345 related articles for article (PubMed ID: 8039760)
1. Fibrinogen survival and fibrinopeptide A in acute leukemia.
Castaman G; Galloni E; Dri AV; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
[TBL] [Abstract][Full Text] [Related]
2. High fibrinopeptide A (FPA) levels in acute non-lymphocytic leukemia are reduced by heparin administration.
Gugliotta L; Viganò S; D'Angelo A; Guarini A; Tura S; Mannucci PM
Thromb Haemost; 1984 Dec; 52(3):301-4. PubMed ID: 6531754
[TBL] [Abstract][Full Text] [Related]
3. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
Yoda Y; Abe T
Thromb Haemost; 1981 Dec; 46(4):706-9. PubMed ID: 7330820
[TBL] [Abstract][Full Text] [Related]
4. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
5. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Mombelli G; Monotti R; Haeberli A; Straub PW
Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
[TBL] [Abstract][Full Text] [Related]
6. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
[TBL] [Abstract][Full Text] [Related]
7. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
[TBL] [Abstract][Full Text] [Related]
8. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias.
Mombelli G; Roux A; Haeberli A; Straub PW
Blood; 1982 Aug; 60(2):381-8. PubMed ID: 7093524
[TBL] [Abstract][Full Text] [Related]
10. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.
Cronlund M; Hardin J; Burton J; Lee L; Haber E; Bloch KJ
J Clin Invest; 1976 Jul; 58(1):142-51. PubMed ID: 932202
[TBL] [Abstract][Full Text] [Related]
11. [Fibrinogen metabolism and plasma fibrinopeptide A in disseminated neoplasms].
Mombelli G; Roux A; Hofmann V; Straub PW
Schweiz Med Wochenschr; 1979 Dec; 109(47):1901. PubMed ID: 531571
[TBL] [Abstract][Full Text] [Related]
12. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
[TBL] [Abstract][Full Text] [Related]
13. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
[TBL] [Abstract][Full Text] [Related]
14. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
15. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
16. [Antithrombin III substitution in patients in shock].
Vinazzer H; Blauhut B; Bergmann H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):806-16. PubMed ID: 6083957
[TBL] [Abstract][Full Text] [Related]
17. Measurement of fibrinopeptide A in human blood.
Nossel HL; Yudelman I; Canfield RE; Butler VP; Spanondis K; Wilner GD; Qureshi GD
J Clin Invest; 1974 Jul; 54(1):43-53. PubMed ID: 4600045
[TBL] [Abstract][Full Text] [Related]
18. Relationship between fibrinopeptide a (FPA) level and fibrinogen kinetics in patients with malignant disease.
Yoda Y; Nakamura H; Abe T
Bibl Haematol; 1983; (49):163-72. PubMed ID: 6667244
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
Rodríguez Gómez M; López Fernández MF; Batlle J
Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the disappearance curve of labelled fibrinogen at the time of hyperfibrinogenemia in rabbits with acute or chronic intravascular coagulation.
Hasegawa H; Watanabe N; Nagata H; Murao M
Thromb Haemost; 1976 Aug; 36(1):49-59. PubMed ID: 1036828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
